technology-news

New nanoparticle vaccine could help protect against flu and other viruses

Washington, Oct 6 : MIT engineers have developed a new type of nanoparticle that protects the vaccine long enough to generate a strong immune response - not only in the lungs, but also in mucosal surfaces far from the vaccination site, such as the gastrointestinal and reproductive tracts.


Such vaccines could help protect against influenza and other respiratory viruses, or prevent sexually transmitted diseases such as HIV, herpes simplex virus and human papilloma virus, Darrell Irvine, an MIT professor of materials science and engineering and biological engineering and the leader of the research team, said.

He is also exploring use of the particles to deliver cancer vaccines.

"This is a good example of a project where the same technology can be applied in cancer and in infectious disease. It's a platform technology to deliver a vaccine of interest," Irvine, who is a member of MIT's Koch Institute for Integrative Cancer Research and the Ragon Institute of Massachusetts General Hospital, MIT and Harvard University, said.

Only a handful of mucosal vaccines have been approved for human use; the best-known example is the Sabin polio vaccine, which is given orally and absorbed in the digestive tract. There is also a flu vaccine delivered by nasal spray, and mucosal vaccines against cholera, rotavirus and typhoid fever.

To create better ways of delivering such vaccines, Irvine and his colleagues built upon a nanoparticle they developed two years ago.

The protein fragments that make up the vaccine are encased in a sphere made of several layers of lipids that are chemically "stapled" to one another, making the particles more durable inside the body.

This allows the particles to resist disintegration once they reach the lungs.

With this sturdier packaging, the protein vaccine remains in the lungs long enough for immune cells lining the surface of the lungs to grab them and deliver them to T cells.

Activating T cells is a critical step for the immune system to form a memory of the vaccine particles so it will be primed to respond again during an infection.

The research is published in the journal Science Translational Medicine.

--ANI (Posted on 06-10-2013)

technology-news headlines

NASA satellites show drought may take toll on Congo rainforest

Video games of the future to adapt to players' mood

World's oldest woman's blood hints at lifespan limits

How ravens maintain their social relations

Microbes help understand evolution of human language

Radiation exposure puts astronauts at risk of cognitive impairment: Study

Iceberg larger that island of Guam drifts away from Antarctic glacier

Manned mission to Mars necessary for our species to survive, says NASA chief

Gene therapy helps reverse loss of memory in mice suffering from Alzheimer's

New technology helps detect when drivers are about to nod off

Technology to catch dozing drivers on the go

This space selfie not to be missed!

Quick Links: Goa | Munnar | Pondicherry | Free Yearly Horoscope '2014

Comments

Your e-mail:


Your Full Name:


Type verification image:
verification image, type it in the box

Message:

Back to Top